Kenny Roose

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

Pandemic preparedness: toward a universal influenza vaccine.

M2e-based universal influenza A vaccine.

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective.

A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection.

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.

Hepatitis B core-based virus-like particles to present heterologous epitopes.

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.

Influenza vaccines to control influenza-associated bacterial infection: where do we stand?

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.

Sequence-dependent internalization of aggregating peptides.

Structure of the extracellular domain of matrix protein 2 of influenza a virus in complex with a protective monoclonal antibody.

A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody.

Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.

A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection.

Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses.

Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.

Influenza and Memory T Cells: How to Awake the Force.

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.

Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection.